临床研究
Copyright ©The Author(s) 2023.
世界华人消化杂志. 2023-04-28; 31(8): 326-333
在线出版 2023-04-28. doi: 10.11569/wcjd.v31.i8.326
表5 两组血糖水平变化情况(mean±SD)
项目组别n治疗前治疗4 wk后治疗8 wk后FP
FPG(mmol/L)观察组1009.78±1.138.11±0.97a6.16±0.82a340.734<0.001
对照组1009.84±1.028.32±0.83a7.32±0.91a188.879<0.001
t0.3941.6459.470
P0.6940.102<0.001
HbA1c(%)观察组1009.17±0.718.22±0.64a7.11±0.75a216.034<0.001
对照组1009.25±0.788.33±0.72a8.03±0.71a74.339<0.001
t0.7591.1428.908
P0.4490.255<0.001
2hPG(mmol/L)观察组10013.26±2.1211.51±1.54a8.57±1.13a206.9420.081
对照组10013.21±2.1011.85±1.65a9.92±1.25a94.299<0.001
t0.6181.5068.012
P0.8670.134<0.001

引文著录: 陈秀梅, 雷旭伟, 吴筱芬. 微生态制剂联合二甲双胍在T2DM伴IBS中的应用效果分析. 世界华人消化杂志 2023; 31(8): 326-333